NCT06015620 Comorbidities Resolution After MGB Surgery and Change in Body Composition
| NCT ID | NCT06015620 |
| Status | Recruiting |
| Phase | — |
| Sponsor | All India Institute of Medical Sciences, Bhubaneswar |
| Condition | Morbid Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 35 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 35 participants in total. It began in 2023-09-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study aims to learn about the correlation between the improving comorbidities associated with obesity after MGB (Mini-Gastric Bypass) surgery and changes in body composition in morbidly obese patients. The main questions it aims to answer are: To study the correlation between the improving comorbidities associated with obesity after MGB(Mini-Gastric Bypass) surgery and changes in body composition. Other objectives are: * Changes in the parameters of the metabolic syndrome after surgery * Changes in the cardiovascular risk biomarkers after metabolic surgery * Emergence in complications arising out of surgery requiring any intervention or causing a prolonged hospital stay, or requiring additional outpatient visits. Type of Study: An observational study in which participants with morbid obesity will undergo mini-gastric bypass surgery as per routine protocol. No separate experimental interventions will be done in the study for the participants.
Eligibility Criteria
Inclusion Criteria: * All patients undergoing laparoscopic MGB surgery for morbid obesity and it's associated comorbidities Exclusion Criteria: * Patients not giving consent for the study * All patients who were undergoing a redo-procedure for recurrence were excluded from the study
Contact & Investigator
Prakash K Sasmal, MS, FACS
PRINCIPAL INVESTIGATOR
All India Institute of Medical Sciences, Bhubaneswar, India
Frequently Asked Questions
Who can join the NCT06015620 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Morbid Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06015620 currently recruiting?
Yes, NCT06015620 is actively recruiting participants. Contact the research team at drpksasmal@gmail.com for enrollment information.
Where is the NCT06015620 trial being conducted?
This trial is being conducted at Bhubaneswar, India.
Who is sponsoring the NCT06015620 clinical trial?
NCT06015620 is sponsored by All India Institute of Medical Sciences, Bhubaneswar. The principal investigator is Prakash K Sasmal, MS, FACS at All India Institute of Medical Sciences, Bhubaneswar, India. The trial plans to enroll 35 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.